For its third fiscal quarter (ending September 30), DENTSPLY SIRONA Inc (NASDAQ: XRAY) has reported E.P.S. of $-1.25 compared to $-5.01 a year ago. This performance was $-1.74 short of the consensus estimate of $0.49. E.P.S. were $-1.01 for the latest four quarters through September 30 versus $-3.79 for the same period a year ago.
Recent Price Action
DENTSPLY SIRONA Inc (NASDAQ: XRAY) stock suffered a very large decline of -7.5% on 11/2/23. The shares closed at $28.54. The stock has performed in line with the market over the last nine months and has declined -10.3% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to exceed the cost of capital, XRAY is expected to continue to be an important Value Builder.
DENTSPLY SIRONA has a current Value Trend Rating of D (Negative). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. DENTSPLY SIRONA has a neutral Power Rating of 43 and a slightly negative Appreciation Score of 30, and the Negative Value Trend Rating results.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment